期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

食管癌放疗靶区勾画的原则及相关问题 被引量：3

原文传递
导出
摘要 食管癌放疗失败的主要原因是肿瘤局部未控或复发，而射线的精确施照与靶区的精确勾画是影响食管癌放疗疗效的两大主要因素。近年来，随着精确放疗技术和放疗设备的快速发展，射线的精确施照技术已有了很大提高，但是食管癌放疗疗效的提高并不显著。因此，靶区精确勾画就显得尤为重要。
作者 孟雪 于金明
机构地区 山东省肿瘤医院放疗科
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第11期801-803,共3页 Chinese Journal of Oncology
关键词 食管肿瘤 放射疗法 靶区 Esophageal neoplasms Radiotherapy Tumor volume
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献12

  • 1袁双虎,于金明,于甬华,杨新华,付政,杨国仁,郭洪波,王晓航,周英智,陈少卿.^(18)F-脱氧葡萄糖PET-CT检测食管癌病变长度的临床价值[J].中华放射肿瘤学杂志,2006,15(5):389-392. 被引量：46
  • 2Zhong X,Yu J,Zhang B,et al.Usiing 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinonm of the esophagus.Int J Radiat Oncol Biol Phys,2009,73:136-141.
  • 3Moureau-Zabotto L,Touboul E,Lerouge D,et al.Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.Int J Radiat Oncol Bid Plays,2005,63:340-345.
  • 4肖泽芬,杨宗贻,王绿化,张红星,冯勤富,陈东福,周宗玫,张德超,孙克林,程贵余,赫杰.食管癌术后淋巴结转移对生存率的影响和放射治疗的意义[J].中华肿瘤杂志,2004,26(2):112-115. 被引量：95
  • 5Nishimaki T,Tanaka O,Ando N,et al.Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer.Ann Thorac Surg,1999,68:2059-2064.
  • 6Yuan S,Yu J,Chao KS,et al.Additional Value of PET/CT over PET in assessment of locoregiorud lymph nodes in thoracic esophageal squamous cdl cancer.J Nucl Med,2006,47:1255-1259.
  • 7郭洪波,于金明,张百江,朱慧,张为迪,李玲,黄勇,付政,李辉.氟脱氧葡萄糖PET—CT确定食管癌淋巴结放疗靶区的可行性研究[J].中华放射肿瘤学杂志,2007,16(1):10-14. 被引量：18
  • 8Gao XS,Qiao X,Wu F,et al.Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.Int J Radiat Oncol Biol Phys,2007,67:389-396.
  • 9Fujita H,Sueyoshi S,Tanaka T,et al.Three-field dissection for squamous cell carcinoma in the thoracic esophagus.Ann Thorac Cardiovasc Surg,2002,8:328-335.
  • 10Lorchel F,Dumas JL,Noel A,et al.Esophageal cancer:determination of internal target volume for corgormal radiotherapy.Badiother Oncol,2006,80:327-332.

二级参考文献29

共引文献247

同被引文献50

  • 1Gerlinger M, Rowan A J, Horswell S, et al. Intratumor heteroge- neity and branched evolution revealed by multiregion sequencing [J]. N Engl J Med, 2012, 366(10) : 883-892.
  • 2International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording, and reporting photo beam therapy [ R ]. Bethesda, MD : Internional Commission on Radiation Units and Measurements, 1993.
  • 3International Commission on Radiation Units and Measurements. ICRU Report 62: Prescribing, recording, and reporting photo beam therapy (Supplement to ICRU Report 50) [ R]. Bethesda, MD: International Commission on Radiation Units and Measure- ments, 1999.
  • 4Hou DL, Shi GF, Gao XS, et al. Improved longitudinal length accuracy of gross tumor volume delineation with diffusion weighted magnetic resonance imaging for esophageal squamous cell carcinoma[ J]. Radiat Oncol, 2013, 8( 1 ) : 169-175.
  • 5Schreurs LM, Busz DM, Paardekooper GM, et al. Impact of 18- fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variabilit~c:PET/CT improves esophageal target def- inition[J]. Dis Esophagus, 2010, 23(6) : 493-501.
  • 6Hatt M, Visvikis D, Albarghach NM, et al. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology [ J ]. Eur J Nucl Med Mol Imaging, 2011, 38(7) : 1191-1202.
  • 7Han D, Yu J, Yu Y, et al. Comparison of(18) F-fluorothymidine and(18) F-fluorodeoxyglueose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carci- noma of thoracic esophagus [J]. Int J Radiat Oncol Biol Phys, 2010, 76(4) : 1235-1241.
  • 8Konski A, Doss M, Milestone B, et al. The integration of 18-fluo- ro-deoxyglucose positron emission tomography and endoscopic ul- trasound in the treatment-planning process for esophagealcarcinoma[J]. Int J Radlat Oncol Biol Phys, 2005, 61 (4) : 1123-1128.
  • 9Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic fac- tors for the survival of patients with esophageal carcinoma in the U. S. :the importance of tumor length and lymph node status[ J]. Cancer, 2002, 95(7): 1434-1443.
  • 10Gao XS, Qiao X, Wu F, et al. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma [ J ]. Int J Radiat Oncol Biol Phys, 2007, 67(2): 389-396.

引证文献3

二级引证文献12

中华肿瘤杂志
2009年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部